Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 30, 2012

 

 

MEDICAL PROPERTIES TRUST, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

Commission File Number 001-32559

 

Maryland   20-0191742

(State or other jurisdiction

of incorporation or organization )

 

(I. R. S. Employer

Identification No.)

1000 Urban Center Drive, Suite 501

Birmingham, AL

  35242
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code

(205) 969-3755

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On October 30, 2012, Medical Properties Trust, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2012. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, this information shall not be deemed incorporated by reference in any filing of Medical Properties Trust, Inc. with the Securities and Exchange Commission, except as expressly set forth by specific reference in any such filing.

The Company disclosed three non-GAAP financial measures in the attached press release for the three and nine months ended September 30, 2012: Funds from operations, Normalized funds from operations and Adjusted funds from operations. The most directly comparable GAAP financial measure to each of these non-GAAP financial measures is net income, which was $31.5 million, or $0.23 per diluted share for the three months ended September 30, 2012 compared to $0.4 million, or $— per diluted share for the three months ended September 30, 2011. For the nine months ended September 30, 2012 net income was $61.3 million, or $0.46 per diluted share compared to $13.8 million, or $0.12 per diluted share for the nine months ended September 30, 2011. In the attached press release, the Company disclosed Funds from operations of $31.3 million and $79.8 million for the three and nine months ended September 30, 2012, respectively, and Normalized funds from operations of $33.4 million and $85.5 million for the three and nine months ended September 30, 2012, respectively. Adjusted funds from operations were disclosed in the press release as $32.0 million and $84.8 million for the three and nine months ended September 30, 2012, respectively.

A reconciliation of the non-GAAP financial measures to net income as well as a statement disclosing the reasons why the Company’s management believes that presentation of these non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations are included in Exhibits 99.1 and 99.2.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit Number

  

Description

99.1    Press release dated October 30, 2012 reporting financial results for the three and nine months ended September 30, 2012
99.2    Medical Properties Trust, Inc. 3rd Quarter 2012 Supplemental Information

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

MEDICAL PROPERTIES TRUST, INC.

(Registrant)

    By:   /s/ R. Steven Hamner
      R. Steven Hamner
     

Executive Vice President

and Chief Financial Officer

(Principal Financial and Accounting Officer)

Date: October 30, 2012

 

 

3


INDEX TO EXHIBITS

 

Exhibit Number

  

Description

99.1    Press release dated October 30, 2012 reporting financial results for the three and nine months ended September 30, 2012
99.2    Medical Properties Trust, Inc. 3rd Quarter 2012 Supplemental Information

 

 

4

EX-99.1

Exhibit 99.1

 

LOGO

 

  

Contact: Charles Lambert

Managing Director – Capital Markets

Medical Properties Trust, Inc.

(205) 397-8897

clambert@medicalpropertiestrust.com

MEDICAL PROPERTIES TRUST, INC. REPORTS

STRONG GROWTH DURING THIRD QUARTER

Raising 2012 Normalized FFO Per Share Guidance;

$781 Million Year-to-Date in Acquisitions and Commitments

Birmingham, AL – October 30, 2012 – Medical Properties Trust, Inc. (the “Company”) (NYSE: MPW) today announced financial and operating results for the third quarter and nine months ended September 30, 2012.

THIRD QUARTER AND RECENT HIGHLIGHTS

 

   

Achieved third quarter Normalized Funds from Operations (“FFO”) and Adjusted FFO (“AFFO”) per diluted share of $0.25 and $0.24, respectively, compared with $0.18 per diluted share for both FFO and AFFO in the third quarter of 2011;

 

   

Invested $210 million in new acute care hospital assets with first year cash returns exceeding 10%;

 

   

Agreed to fund additional $149 million in hospital acquisitions and developments, bringing year-to-date acquisitions and commitments total to approximately $781 million;

 

   

Sold two post-acute properties for $42 million, reflecting a 260 point compression in market capitalization rates;

 

   

Paid 2012 third quarter cash dividend of $0.20 per share, representing an 80% Normalized FFO dividend payout ratio.

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to FFO and AFFO, all on a comparable basis to 2011 periods.

“We are executing our dynamic acquisition and operating investment strategy and this is continuing to drive strong financial results,” said Edward K. Aldag, Jr., Chairman, President and CEO of Medical Properties Trust. “For the second consecutive quarter we achieved FFO growth per share of more than 35% while continuing to build a diversified portfolio based on tenant, property and geographic mix. As we expected, our third quarter FFO payout ratio improved to 80% and our recent acquisitions should drive our in-place portfolio FFO payout ratio to 74%. We continue to exceed our lease and EBITDAR coverage targets, which consistently lead the industry and contribute to the cap rate compression demonstrated by our recent property sales.”

 

1


OPERATING RESULTS

MPT’s continued successful execution of its growth and investment strategies have driven the Company’s strong results. Since 2010, MPT has made hospital investments totaling more than $1.0 billion with average returns of more than 10%.

Third quarter 2012 total revenues increased 55% to $53.7 million compared with $34.6 million for the third quarter of 2011. Normalized FFO for the quarter increased 71% to $33.4 million compared with $19.5 million in the third quarter of 2011. Per share Normalized FFO increased 39% to $0.25 per diluted share during the 2012 third quarter, compared with $0.18 per diluted share in the third quarter of 2011. The FFO dividend payout ratio for the third quarter of 2012 was 80%, an 11% improvement compared with the second quarter of 2012.

Net income for the third quarter of 2012 was $31.5 million (or $0.23 per diluted share) compared with net income of $0.4 million (or $0.00 per diluted share) during the third quarter of 2011.

For the nine months ended September 30, 2012 normalized FFO was $85.5 million (or $0.65 per diluted share) compared with $57.5 million (or $0.52 per diluted share) in the corresponding period in 2011. Revenue for the nine months ended September 30, 2012 was $145 million compared to $102 million in the corresponding period in 2011. Net income for the first nine months of 2012 was $61.3 million compared with $13.8 million in 2011.

PORTFOLIO UPDATE AND FUTURE OUTLOOK

Since June 30, 2012, the Company has made investments in acute care hospitals aggregating $210 million, including hospitals in Roxborough, PA and Reno, NV operated by Prime Healthcare, and the previously announced $100 million Centinela Hospital Medical Center transaction. MPT has commenced development of an $18 million post acute facility for Ernest Health in Spartanburg, SC. In addition, MPT expects to acquire two post acute care hospitals in the fourth quarter for an aggregate investment of $31 million that are subject to executed letters of intent with two existing MPT operators.

MPT also recently executed a letter of intent with First Choice ER, LLC, to provide sale / leaseback financing for up to 25 freestanding emergency room facilities for an aggregate investment of $100 million. The First Choice system is a leader in the rapidly growing field of emergency services, and staffs all of its free standing emergency rooms with board certified emergency physicians. MPT expects all of the facilities, which are targeted for high traffic retail locations, to be under construction by the second quarter of 2014.

During and subsequent to the 2012 third quarter, the Company sold two post acute care hospitals in Colorado and Massachusetts for an aggregate $42 million cash sales price. A gain of

 

2


$8.4 million gain was recognized in the third quarter, and a non-cash charge of $1.6 million was recorded for accrued straight line rent. In the fourth quarter, the Company expects to report a gain of approximately $7.0 million for the sale of the Massachusetts property and a charge for accrued straight line rent of $4.1 million. At the $42 million combined sales price, the transaction delivers a capitalization rate of 260 basis points lower than the current annual base lease rate and the sales prices was 27% greater than MPT’s original cost. The Company believes that this capitalization rate compression for two of its older properties is a good benchmark for estimating the overall asset value of its portfolio.

At September 30, 2012, the Company had total real estate and related investments of approximately $2.1 billion comprised of 79 healthcare properties in 24 states leased or loaned to 21 hospital operating companies.

Based on the Company’s asset portfolio and capitalization as of September 30, 2012, and adjusting for the sale of the Massachusetts facility as well as the placement into service of the Emerus emergency hospitals, the Company is increasing its expectation for Normalized FFO to $0.90 per diluted share for calendar year 2012.

Based upon its expected 2012 performance and placement of its properties under construction into service, MPT expects to enter 2013 with a Normalized FFO run rate of approximately $1.08 per diluted share. This does not include the impact of any potential 2013 acquisitions or financing activities.

Guidance estimates do not include the effects, if any, of real estate operating costs, litigation costs, debt refinancing costs, acquisition costs, new interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates will change if the Company acquires additional assets, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, assets are sold, other operating expenses vary, income from investments in tenant operations vary from expectations, or existing leases do not perform in accordance with their terms.

DECLARES QUARTERLY DIVIDEND

Medical Properties Trust, Inc. announced today that its Board of Directors declared a regular quarterly cash dividend of $0.20 per share of common stock to be paid on January 5, 2013 to stockholders of record on November 23, 2012.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for Tuesday, October 30, 2012 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended September 30, 2012. The dial-in telephone numbers for the conference call 800-531-3039 (U.S.) and 847-413-4850 (International); using passcode 33605670. The conference call will also be available via webcast in the Investor Relations’ section of the Company’s website, www.medicalpropertiestrust.com.

 

3


A telephone and webcast replay of the call will be available from shortly after the completion of the call through November 6, 2012. Telephone numbers for the replay are 888-843-7419 and 630-652-3042 for U.S. and International callers, respectively. The replay passcode is 33605670.

The Company’s supplemental information package for the current period will also be available on the Company’s website under the “Investor Relations” section.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional acute care hospitals, ambulatory surgery centers and other single-discipline healthcare facilities, such as heart hospitals and orthopedic hospitals. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the capacity of the Company’s tenants to meet the terms of their agreements; Normalized FFO per share; expected payout ratio, the amount of acquisitions of healthcare real estate, if any; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the restructuring of the Company’s investments in non-revenue producing properties; the payment of future dividends, if any; completion of additional debt arrangement, and additional investments; national and economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for federal income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, as amended, and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.

# # #

 

4


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

 

     September 30, 2012     December 31, 2011  
     (Unaudited)     (A)  

Assets

    

Real estate assets

    

Land, buildings and improvements, and intangible lease assets

   $ 1,225,753,769      $ 1,186,656,442   

Construction in progress and other

     26,154,688        30,902,348   

Real estate held for sale

     17,432,421        48,925,401   

Net investment in direct financing leases

     312,050,375        —     

Mortgage loans

     368,650,000        165,000,000   
  

 

 

   

 

 

 

Gross investment in real estate assets

     1,950,041,253        1,431,484,191   

Accumulated depreciation and amortization

     (120,215,169     (94,823,124
  

 

 

   

 

 

 

Net investment in real estate assets

     1,829,826,084        1,336,661,067   

Cash and cash equivalents

     36,162,730        102,725,906   

Interest and rent receivable

     42,093,846        29,862,106   

Straight-line rent receivable

     38,065,621        33,993,032   

Other loans

     158,176,919        74,839,459   

Deferred financing costs

     22,024,564        18,285,175   

Other assets

     32,049,518        25,506,974   
  

 

 

   

 

 

 

Total Assets

   $ 2,158,399,282      $ 1,621,873,719   
  

 

 

   

 

 

 

Liabilities and Equity

    

Liabilities

    

Debt, net

   $ 1,025,182,763      $ 689,848,981   

Accounts payable and accrued expenses

     64,297,021        51,124,723   

Deferred revenue

     20,374,583        23,307,074   

Lease deposits and other obligations to tenants

     15,387,183        28,777,787   
  

 

 

   

 

 

 

Total liabilities

     1,125,241,550        793,058,565   

Equity

    

Preferred stock, $0.001 par value. Authorized 10,000,000 shares; no shares outstanding

     —          —     

Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding - 134,657,087 shares at September 30, 2012 and 110,786,183 shares at December 31, 2011

     134,657        110,786   

Additional paid in capital

     1,280,769,604        1,055,255,776   

Distributions in excess of net income

     (234,264,221     (214,058,258

Accumulated other comprehensive income (loss)

     (13,219,965     (12,230,807

Treasury shares, at cost

     (262,343     (262,343
  

 

 

   

 

 

 

Total Equity

     1,033,157,732        828,815,154   
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 2,158,399,282      $ 1,621,873,719   
  

 

 

   

 

 

 

 

(A) Financials have been derived from the prior year audited financials.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

 

     For the Three Months Ended     For the Nine Months Ended  
     September 30, 2012     September 30, 2011     September 30, 2012     September 30, 2011  
           (A)           (A)  

Revenues

        

Rent billed

   $ 31,083,000      $ 27,760,422      $ 93,100,167      $ 81,085,771   

Straight-line rent

     2,762,061        1,643,058        5,472,683        5,318,318   

Income from direct financing leases

     5,773,138        —          12,979,142        —     

Interest and fee income

     14,037,030        5,228,641        33,485,602        15,713,384   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     53,655,229        34,632,121        145,037,594        102,117,473   

Expenses

        

Real estate depreciation and amortization

     8,491,249        7,700,565        25,392,047        22,508,942   

Property-related

     218,429        260,611        1,044,055        346,947   

Acquisition expenses

     410,426        529,880        4,114,696        3,185,933   

General and administrative

     7,052,618        5,736,691        21,341,288        20,429,007   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     16,172,722        14,227,747        51,892,086        46,470,829   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     37,482,507        20,404,374        93,145,508        55,646,644   

Other income (expense)

        

Interest and other income (expense)

     (23,266     41,951        (54,987     (12,941

Earnings from equity and other interests

     1,064,730        9,276        1,943,816        70,392   

Debt refinancing costs

     —          (10,425,037     —          (14,214,036

Interest expense

     (15,045,519     (11,934,770     (42,730,146     (32,460,144
  

 

 

   

 

 

   

 

 

   

 

 

 

Net other expense

     (14,004,055     (22,308,580     (40,841,317     (46,616,729
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

     23,478,452        (1,904,206     52,304,191        9,029,915   

Income from discontinued operations

     8,028,444        2,371,520        9,169,366        4,944,434   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     31,506,896        467,314        61,473,557        13,974,349   

Net income attributable to non-controlling interests

     (43,300     (42,749     (129,822     (130,534
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to MPT common stockholders

   $ 31,463,596      $ 424,565      $ 61,343,735      $ 13,843,815   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share - basic and diluted:

        

Income (loss) from continuing operations

   $ 0.17      $ (0.02   $ 0.39      $ 0.07   

Income from discontinued operations

     0.06        0.02        0.07        0.05   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to MPT common stockholders

   $ 0.23      $ —        $ 0.46      $ 0.12   
  

 

 

   

 

 

   

 

 

   

 

 

 

Dividends declared per common share

   $ 0.20      $ 0.20      $ 0.60      $ 0.60   

Weighted average shares outstanding - basic

     134,780,992        110,713,843        131,467,285        110,567,618   

Weighted average shares outstanding - diluted

     134,781,577        110,719,144        131,467,480        110,575,784   

 

(A) Financials have been restated to reclass the operating results of certain properties sold in December 2011 and the first nine months of 2012 along with one property held for sale at September 30, 2012 to discontinued operations.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Reconciliation of Net Income to Funds From Operations

(Unaudited)

 

     For the Three Months Ended     For the Nine Months Ended  
     September 30, 2012     September 30, 2011     September 30, 2012     September 30, 2011  
           (A)           (A)  

FFO information:

        

Net income attributable to MPT common stockholders

   $ 31,463,596      $ 424,565      $ 61,343,735      $ 13,843,815   

Participating securities’ share in earnings

     (224,867     (263,756     (714,901     (860,426
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income, less participating securities’ share in earnings

   $ 31,238,729      $ 160,809      $ 60,628,834      $ 12,983,389   

Depreciation and amortization:

        

Continuing operations

     8,491,249        7,700,565        25,392,047        22,508,942   

Discontinued operations

     310,783        729,188        1,021,048        2,169,090   

Loss (gain) on sale of real estate

     (8,725,735     —          (7,280,180     (5,324

Real estate impairment charge

     —          —          —          564,005   
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 31,315,026      $ 8,590,562      $ 79,761,749      $ 38,220,102   

Write-off straight line rent

     1,639,839        —          1,639,839        —     

Acquisition costs

     410,426        529,880        4,114,696        3,185,933   

Debt refinancing costs

     —          10,425,037        —          14,214,036   

Write-off of other receivables

     —          —          —          1,845,968   
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 33,365,291      $ 19,545,479      $ 85,516,284      $ 57,466,039   

Share-based compensation

     1,793,476        1,631,372        5,430,185        5,292,678   

Debt costs amortization

     867,193        773,206        2,578,020        2,771,268   

Additional rent received in advance (B)

     (300,000     (300,000     (900,000     (900,000

Straight-line rent revenue and other

     (3,756,682     (1,802,124     (7,789,434     (5,816,986
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 31,969,278      $ 19,847,933      $ 84,835,055      $ 58,812,999   
  

 

 

   

 

 

   

 

 

   

 

 

 

Per diluted share data:

        

Net income, less participating securities’ share in earnings

   $ 0.23      $ —        $ 0.46      $ 0.12   

Depreciation and amortization:

        

Continuing operations

     0.06        0.07        0.19        0.20   

Discontinued operations

     —          0.01        0.01        0.02   

Loss (gain) on sale of real estate

     (0.06     —          (0.05     —     

Real estate impairment charge

     —          —          —          0.01   
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 0.23      $ 0.08      $ 0.61      $ 0.35   

Write-off straight line rent

     0.01        —          0.01        —     

Acquisition costs

     0.01        0.01        0.03        0.03   

Debt refinancing costs

     —          0.09        —          0.13   

Write-off of other receivables

     —          —          —          0.01   
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 0.25      $ 0.18      $ 0.65      $ 0.52   

Share-based compensation

     0.01        0.01        0.04        0.05   

Debt costs amortization

     0.01        0.01        0.02        0.02   

Additional rent received in advance (B)

     —          —          —          (0.01

Straight-line rent revenue and other

     (0.03     (0.02     (0.06     (0.05
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 0.24      $ 0.18      $ 0.65      $ 0.53   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(A) Financials have been restated to reclass to discontinued operations the operating results of certain properties sold in December 2011 and the first nine months of 2012 along with one property held for sale at September 30, 2012.
(B) Represents additional rent from one tenant in advance of when we can recognize as revenue for accounting purposes. This additional rent is being recorded to revenue on a straight-line basis over the lease life.

Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.

EX-99.2

Exhibit 99.2

 

LOGO

Investing in the future of healthcare.

MPT Medical Properties Trust

THIRD QUARTER 2012 SUPPLEMENTAL INFORMATION


LOGO    

Table of Contents

 

  
 

Company Information

     1   
 

Reconciliation of Net Income to Funds from Operations

     2   
 

Investment and Revenue by Asset Type, Operator and by State

     3   
 

Lease Maturity Schedule

     4   
 

Debt Summary

     5   
 

Consolidated Balance Sheets

     6   
 

Acquisitions and Operating Investments and Related Results

     7   
 

The information in this supplemental information package should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the Securities and Exchange Commission. You can access these documents free of charge at www.sec.gov and from the Company’s website at www.medicalpropertiestrust. com. The information contained on the Company’s website is not incorporated by reference into, and should not be considered a part of, this supplemental package.

 

For more information, please contact:

 

Charles Lambert, Managing Director - Capital Markets at (205) 397-8897.

       

  

  

 

LOGO


LOGO

Company Information

Headquarters:

Medical Properties Trust, Inc.

1000 Urban Center Drive, Suite 501

Birmingham, AL 35242

(205) 969-3755

Fax: (205) 969-3756

Website: www.medicalpropertiestrust.com

Executive Officers: Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer

R. Steven Hamner, Executive Vice President and Chief Financial Officer

Emmett E. McLean, Executive Vice President, Chief Operating Officer, Secretary and Treasurer

Investor Relations: Medical Properties Trust, Inc.

1000 Urban Center Drive, Suite 501

Birmingham, AL 35242

Attn: Charles Lambert

(205) 397-8897

clambert@medicalpropertiestrust.com

MPW

LISTED

NYSE.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Reconciliation of Net Income to Funds From Operations

(Unaudited)

 

     For the Three Months Ended     For the Nine Months Ended  
     September 30, 2012     September 30, 2011     September 30, 2012     September 30, 2011  
           (A)           (A)  

FFO information:

        

Net income attributable to MPT common stockholders

   $ 31,463,596      $ 424,565      $ 61,343,735      $ 13,843,815   

Participating securities’ share in earnings

     (224,867     (263,756     (714,901     (860,426
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income, less participating securities’ share in earnings

   $ 31,238,729      $ 160,809      $ 60,628,834      $ 12,983,389   

Depreciation and amortization:

        

Continuing operations

     8,491,249        7,700,565        25,392,047        22,508,942   

Discontinued operations

     310,783        729,188        1,021,048        2,169,090   

Loss (gain) on sale of real estate

     (8,725,735     —          (7,280,180     (5,324

Real estate impairment charge

     —          —          —          564,005   
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 31,315,026      $ 8,590,562      $ 79,761,749      $ 38,220,102   

Write-off straight line rent

     1,639,839        —          1,639,839        —     

Acquisition costs

     410,426        529,880        4,114,696        3,185,933   

Debt refinancing costs

     —          10,425,037        —          14,214,036   

Write-off of other receivables

     —          —          —          1,845,968   
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 33,365,291      $ 19,545,479      $ 85,516,284      $ 57,466,039   

Share-based compensation

     1,793,476        1,631,372        5,430,185        5,292,678   

Debt costs amortization

     867,193        773,206        2,578,020        2,771,268   

Additional rent received in advance (B)

     (300,000     (300,000     (900,000     (900,000

Straight-line rent revenue and other

     (3,756,682     (1,802,124     (7,789,434     (5,816,986
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 31,969,278      $ 19,847,933      $ 84,835,055      $ 58,812,999   
  

 

 

   

 

 

   

 

 

   

 

 

 

Per diluted share data:

        

Net income, less participating securities’ share in earnings

   $ 0.23      $ —        $ 0.46      $ 0.12   

Depreciation and amortization:

        

Continuing operations

     0.06        0.07        0.19        0.20   

Discontinued operations

     —          0.01        0.01        0.02   

Loss (gain) on sale of real estate

     (0.06     —          (0.05     —     

Real estate impairment charge

     —          —          —          0.01   
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 0.23      $ 0.08      $ 0.61      $ 0.35   

Write-off straight line rent

     0.01        —          0.01        —     

Acquisition costs

     0.01        0.01        0.03        0.03   

Debt refinancing costs

     —          0.09        —          0.13   

Write-off of other receivables

     —          —          —          0.01   
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 0.25      $ 0.18      $ 0.65      $ 0.52   

Share-based compensation

     0.01        0.01        0.04        0.05   

Debt costs amortization

     0.01        0.01        0.02        0.02   

Additional rent received in advance (B)

     —          —          —          (0.01

Straight-line rent revenue and other

     (0.03     (0.02     (0.06     (0.05
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 0.24      $ 0.18      $ 0.65      $ 0.53   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(A) Financials have been restated to reclass to discontinued operations the operating results of certain properties sold in December 2011 and the first nine months of 2012 along with one property held for sale at September 30, 2012.
(B) Represents additional rent from one tenant in advance of when we can recognize as revenue for accounting purposes. This additional rent is being recorded to revenue on a straight-line basis over the lease life.

Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.

 

   2    LOGO


INVESTMENT AND REVENUE BY ASSET TYPE, OPERATOR AND BY STATE

Investments and Revenue by Asset Type - As of September 30, 2012

 

     Total
Assets
    Percentage
of Total Assets
    Total
Revenue
     Percentage
of Total Revenue
 

General Acute Care Hospitals

   $ 1,208,284,747        53.0   $ 79,409,988         54.7

Long-Term Acute Care Hospitals

     470,404,815        20.6     37,306,917         25.7

Medical Office Buildings

     15,795,436        0.7     1,389,473         1.0

Rehabilitation Hospitals

     380,675,936        16.7     25,685,198         17.7

Wellness Centers

     15,624,817        0.7     1,246,018         0.9

Other assets

     187,828,700        8.3     —           —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Total gross assets

     2,278,614,451        100.0     

Accumulated depreciation and amortization

     (120,215,169       
  

 

 

        

Total

   $ 2,158,399,282        $ 145,037,594         100.0
  

 

 

     

 

 

    

 

 

 

Investments and Revenue by Operator - As of September 30, 2012

 

     Total
Assets
    Percentage
of Total Assets
    Total
Revenue
     Percentage
of Total Revenue
 

Prime Healthcare

   $ 620,235,427        27.2   $ 38,112,246         26.3

Ernest Health, Inc.

     403,702,058        17.7     26,209,915         18.1

IJKG/HUMC

     126,401,831        5.5     11,333,098         7.8

Vibra Healthcare

     91,238,112        4.0     8,726,128         6.0

Kindred Healthcare

     83,434,567        3.7     6,368,394         4.4

16 other operators

     765,773,756        33.6     54,287,813         37.4

Other assets

     187,828,700        8.3     —           —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Total gross assets

     2,278,614,451        100.0     

Accumulated depreciation and amortization

     (120,215,169       
  

 

 

        

Total

   $ 2,158,399,282        $ 145,037,594         100.0
  

 

 

     

 

 

    

 

 

 

Investment and Revenue by State - As of September 30, 2012

 

     Total
Assets
    Percentage
of Total Assets
    Total
Revenue
     Percentage
of Total Revenue
 

California

   $ 535,345,927        23.5   $ 40,304,155         27.8

Texas

     511,100,353        22.4     36,319,788         25.0

New Jersey

     126,401,831        5.5     11,333,098         7.8

Arizona

     95,819,927        4.2     6,633,483         4.6

Idaho

     85,963,695        3.8     6,975,591         4.8

19 other states

     736,154,018        32.3     43,471,479         30.0

Other assets

     187,828,700        8.3     —           —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Total gross assets

     2,278,614,451        100.0     

Accumulated depreciation and amortization

     (120,215,169       
  

 

 

        

Total

   $ 2,158,399,282        $ 145,037,594         100.0
  

 

 

     

 

 

    

 

 

 

 

   3    LOGO


LEASE MATURITY SCHEDULE - AS OF SEPTEMBER 30, 2012

 

Total portfolio (1)

   Total leases      Base rent (2)      Percent of total
base rent
 

2012

     3       $ 4,285,924         2.8

2013

     —           —           0.0

2014

     2         4,811,508         3.2

2015

     2         4,039,476         2.6

2016

     1         2,250,000         1.5

2017

     —           —           0.0

2018

     1         1,927,452         1.3

2019

     8         10,151,490         6.7

2020

     1         1,039,728         0.7

2021

     4         12,487,514         8.2

2022

     13         39,091,300         25.7

2023

     1         1,216,872         0.8

2024

     1         2,232,504         1.5

Thereafter

     30         68,326,081         45.0
  

 

 

    

 

 

    

 

 

 
     67       $ 151,859,849         100.0
  

 

 

    

 

 

    

 

 

 

 

(1) Excludes our River Oaks facility, as it is currently under re-development and our five facilities that are under development.
(2) The most recent monthly base rent annualized. Base rent does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues).

 

   4    LOGO


DEBT SUMMARY AS OF SEPTEMBER 30, 2012

 

Instrument

  Rate Type   Rate     Balance     2012     2013     2014     2015     2016     Thereafter  

6.875% Notes Due 2021

  Fixed     6.88   $ 450,000,000      $ —        $ —        $ —        $ —        $ —        $ 450,000,000   

6.375% Notes Due 2022

  Fixed     6.38     200,000,000        —          —          —          —          —          200,000,000   

2011 Credit Facility Revolver

  Variable     3.10 % (1)      125,000,000        —          —          —          125,000,000        —          —     

2016 Term Loan

  Variable     2.48     100,000,000        —          —          —          —          100,000,000        —     

2016 Unsecured Notes

  Fixed     5.59 % (2)      125,000,000        —          —          —          —          125,000,000        —     

2008 Exchangeable Notes

  Fixed     9.25     11,000,000        —          11,000,000        —          —          —          —     

Northland - Mortgage Capital Term Loan

  Fixed     6.20     14,258,020        60,537        249,384        265,521        282,701        298,582        13,101,295   
     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
      $ 1,025,258,020      $ 60,537      $ 11,249,384      $ 265,521      $ 125,282,701      $ 225,298,582      $ 663,101,295   
     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
      Debt Discount        (75,257            
     

 

 

             
      $ 1,025,182,763               
     

 

 

             

 

(1) Represents a $400 million unsecured revolving credit facility with spreads over LIBOR ranging from 2.60% to 3.40%.
(2) Represents the weighted-average rate for four traunches of the Notes at September 30, 2012 factoring in interest rate swaps in effect at that time.

The Company has entered into two swap agreements which began in July and October 2011. Effective July 31, 2011, the Company is paying 5.507% on $65 million of the Notes and effective October 31, 2011, the Company is paying 5.675% on $60 million of Notes.

 

   5    LOGO


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

 

     September 30, 2012     December 31, 2011  
     (Unaudited)     (A)  

Assets

    

Real estate assets

    

Land, buildings and improvements, and intangible lease assets

   $ 1,225,753,769      $ 1,186,656,442   

Construction in progress and other

     26,154,688        30,902,348   

Real estate held for sale

     17,432,421        48,925,401   

Net investment in direct financing leases

     312,050,375        —     

Mortgage loans

     368,650,000        165,000,000   
  

 

 

   

 

 

 

Gross investment in real estate assets

     1,950,041,253        1,431,484,191   

Accumulated depreciation and amortization

     (120,215,169     (94,823,124
  

 

 

   

 

 

 

Net investment in real estate assets

     1,829,826,084        1,336,661,067   

Cash and cash equivalents

     36,162,730        102,725,906   

Interest and rent receivable

     42,093,846        29,862,106   

Straight-line rent receivable

     38,065,621        33,993,032   

Other loans

     158,176,919        74,839,459   

Deferred financing costs

     22,024,564        18,285,175   

Other assets

     32,049,518        25,506,974   
  

 

 

   

 

 

 

Total Assets

   $ 2,158,399,282      $ 1,621,873,719   
  

 

 

   

 

 

 

Liabilities and Equity

    

Liabilities

    

Debt, net

   $ 1,025,182,763      $ 689,848,981   

Accounts payable and accrued expenses

     64,297,021        51,124,723   

Deferred revenue

     20,374,583        23,307,074   

Lease deposits and other obligations to tenants

     15,387,183        28,777,787   
  

 

 

   

 

 

 

Total liabilities

     1,125,241,550        793,058,565   

Equity

    

Preferred stock, $0.001 par value. Authorized 10,000,000 shares; no shares outstanding

     —          —     

Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding - 134,657,087 shares at September 30, 2012 and 110,786,183 shares at December 31, 2011

     134,657        110,786   

Additional paid in capital

     1,280,769,604        1,055,255,776   

Distributions in excess of net income

     (234,264,221     (214,058,258

Accumulated other comprehensive income (loss)

     (13,219,965     (12,230,807

Treasury shares, at cost

     (262,343     (262,343
  

 

 

   

 

 

 

Total Equity

     1,033,157,732        828,815,154   
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 2,158,399,282      $ 1,621,873,719   
  

 

 

   

 

 

 

 

(A) Financials have been derived from the prior year audited financials.

 

   6    LOGO


ACQUISITIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

 

Name

  

Location

  

Property Type

  

Acquisition /
Development

   Investment /
Commitment
 

Ernest Health, Inc.

   Nine states    Long-term acute care and inpatient rehabiliation    Acquisition    $ 396,500,000   

Post Acute Medical

   Victoria, TX    Inpatient rehabilitation    Development      9,400,000   

Ernest Health, Inc.

   Lafayette, IN    Inpatient rehabilitation    Development      16,600,000   

Centinela Hospital Medical Center

   Inglewood, CA    General acute care    Acquisition      100,000,000   

St. Mary’s Regional Medical Center

   Reno, NV    General acute care    Acquisition      80,000,000   

Roxborough Memorial Hospital

   Philadelphia, PA    General acute care    Acquisition      30,000,000   
           

 

 

 

Total Investments / Commitments

            $ 632,500,000   
           

 

 

 

OPERATING INVESTMENTS AND RELATED RESULTS AS OF AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

 

Non-Ernest
Operating Investments
     Operations Revenue     Annualized Return  
$ 10,167,500       $ 1,943,816        38
Ernest Health Inc.
Operating Investment (1)
     Operations Revenue     Annualized Return  
$  96,500,000       $ 8,193,833 (2)      15

Note: The Company’s 2012 estimate for non-Ernest properties’ earnings from equity and other interests in operations is approximately $3.0 million. However, this estimate is for nine months of actuals as we began reporting earnings from equity interests in operations one quarter in arrears starting in 2012; we did not report any earnings from equity interests for the three months ended March 31, 2012.

 

(1) The Ernest Health, Inc. transaction closed on February 29, 2012.
(2) Includes interest from our acquisition note.

 

   7    LOGO


LOGO

MPT

Medical Properties Trust

Medical Properties Trust, Inc. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 (205) 969-3755 www.medicalpropertiestrust.com

Contact: Charles Lambert, Managing Director - Capital Markets (205) 397-8897 or clambert@medicalpropertiestrust.com